- Home
- UHT
as 05-14-2025 11:44am EST
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | KING OF PRUSSIA |
| Market Cap: | 540.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 46.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.35 | EPS Growth: | 15.38 |
| 52 Week Low/High: | $34.56 - $47.30 | Next Earning Date: | 04-28-2025 |
| Revenue: | $99,725,000 | Revenue Growth: | 1.03% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Universal Health Realty Income Trust News
UHT Breaking Stock News: Dive into UHT Ticker-Specific Updates for Smart Investing
Argus Research
8 days ago
UHT: Raising target price to $43.00
Zacks
14 days ago
Universal Health Realty Stock Gains Despite Earnings and FFO Dip
Associated Press Finance
16 days ago
Universal Health Realty: Q1 Earnings Snapshot
PR Newswire
16 days ago
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS
PR Newswire
16 days ago
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2025 FIRST QUARTER FINANCIAL RESULTS
Argus Research
22 days ago
UHT: Raising target price to $43.00
Argus Research
a month ago
UHT: Raising target price to $42.00
Argus Research
a month ago
UHT: Lowering target price to $40.00
Compare UHT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "UHT Universal Health Realty Income Trust - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.